Supraventricular Tachycardia in Pregnancy: Gestational and Labor Differences in Treatment.

Publication/Presentation Date

10-1-2021

Abstract

Supraventricular tachycardia (SVT) is a tachyarrhythmia characterized by a heart rate above 120 beats per minute (BPM). Patients with SVT exhibit the following symptoms: palpitations, shortness of breath, chest pain, hemodynamic instability, or possibly asymptomatic. The increase in cardiac output and the increase in resting heart rate during pregnancy predispose pregnant women to SVT. The management of SVT in pregnancy, although remarkably similar, varies slightly based on the trimester of pregnancy. Atenolol and verapamil are effective methods of treating SVT, which can be used during the second and third trimesters. Both medications are contraindicated in the first trimester. At the same time, intravenous adenosine can be used in all three trimesters, including labor. Electrical cardioversion is an effective treatment method for hemodynamically unstable or drug-refractory patients, which has proven to be safe in all three trimesters, including labor but can result in pre-term labor in the third trimester. Non-fluoroscopic ablation proved to be the only treatment method that definitively resolved SVT without recurrence.

Volume

13

Issue

10

First Page

18479

Last Page

18479

ISSN

2168-8184

Disciplines

Medicine and Health Sciences

PubMedID

34659918

Department(s)

Hematology-Medical Oncology Division

Document Type

Article

Link to Full Text

Share

COinS